Global Anosmia Market to Surpass US$ 3,950.3 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--()--According to Coherent Market Insights, the global anosmia market is estimated to be valued at US$ 2,500.7 million in 2020 and is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Anosmia Market:

Key trends in the market include rising incidence of anosmia and rising research activities by the market players & research organizations.

The increasing incidence of anosmia is expected to drive the market growth over the forecast period. For instance, according to an article published by the Fifth Sense in 2020, reports that amongst the common smell loss disorders idiopathic anosmia accounts 25% and congenital anosmia holds share of 1% in the U.K.

Rising research activities by the market players to develop novel treatment for anosmia is expected to drive the global anosmia market growth over the forecast period. For instance, in June 2019, Washington University School of Medicine, initiated the Phase II study, in order to evaluate the efficacy and safety of Budesonide in patients with coronavirus smell therapy for anosmia recovery. The study is expected to complete in December 2023.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4334

Key Market Takeaways:

The global anosmia market is expected to exhibit a CAGR of 6.7% during the forecast period (2020-2027), owing to rising product launches by the market players. For instance, in June 2020, Cadila Pharmaceuticals Limited launched Bilastine syrup (30 ml) and Bilastine tablets (20 mg), an antihistamine drug. This drug is used in the treatment of allergic rhinitis, which later develops anosmia.

Among regions, North America is expected to hold a dominant position in the global anosmia market over the forecast period, owing to increasing cases of anosmia in the region. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in 2017, reports that a substantial portion i.e. around 4.3 million people, 65 years or older suffer from anosmia in the U.S.

Competitive Landscape:

Key players operating in the global anosmia market include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.

Buy-Now this Research Report for complete data access @
https://www.coherentmarketinsights.com/insight/buy-now/4334

Market Segmentation:

Global Anosmia Market, By Type

  • Idiopathic Anosmia
  • Congenital Anosmia

Global Anosmia Market, By Treatment

  • Therapies
    • Nasal Endoscopy
    • Imaging
  • Medications
    • Decongestants
    • Antihistamines
    • Steroid Nasal Sprays

Global Anosmia Market, By Region

  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Alagille Syndrome Treatment Market, by Drug (Ursodeoxycholic Acid, Cholestyramine, Rifampicin, Late Stage Pipeline Drugs, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/alagille-syndrome-treatment-market-4398

Pediatric Electrolyte Solution Market, by Type (Sodium, Chloride, Potassium, Calcium, and Magnesium), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/pediatric-electrolyte-solution-market-4344

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter

Release Summary

North America is expected to hold a dominant position in the global anosmia market over the forecast period.

Contacts

Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter